Avatrombopag maleate
- Product NameAvatrombopag maleate
- CAS677007-74-8
- CBNumberCB43159868
- MFC33H38Cl2N6O7S2
- MW765.72
- MDL NumberMFCD12032126
- MOL File677007-74-8.mol
Chemical Properties
InChIKey | MISPBGHDNZYFNM-BTJKTKAUSA-N |
SMILES | C(/C(=O)O)=C/C(=O)O.N(C1SC(N2CCN(C3CCCCC3)CC2)=C(C2SC=C(Cl)C=2)N=1)C(C1=CN=C(N2CCC(C(=O)O)CC2)C(Cl)=C1)=O |
FDA UNII | GDW7M2P1IS |
Avatrombopag maleate Price
Product number | Packaging | Price | Product description | Buy |
---|---|---|---|---|
Chemenu CM328489 | 1000g | $55200 | (Z)-but-2-enedioicacid;1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]pyridin-2-yl]piperidine-4-carboxylicacid 95%+ |
Buy |
Avatrombopag maleate Chemical Properties,Usage,Production
Description
Avatrombopag maleate is a thrombopoietin receptor (TPO) agonist developed by AkaRx Inc and approved by the US FDA in May 2018 as Doptelet (20mg). For the treatment of low platelet count (thrombocytopenia CIT) in adult patients with chronic liver disease (CLD) who are scheduled to undergo medical or dental surgery.Chemical Properties
Avatrombopag maleate drug substance is a white to off-white, non-hygroscopic, powder that is practically insoluble in water and in 0.1 M HCl. The aqueous solubility of avatrombopag maleate at various pH levels indicates that the drug substance is practically insoluble at pH 1 to 11. Avatrombopag maleate drug substance is an achiral molecule.Uses
Avatrombopag Maleate is the maleate salt form of avatrombopag, an orally available platelet thrombopoietin receptor (TPOR; MPL) agonist, with potential megakaryopoiesis stimulating activity.Definition
Avatrombopag maleate is an active ingredient in Doptelet. Doptelet is provided as an immediate-release tablet. Each DOPTELET tablet contains 20 mg avatrombopag (equivalent to 23.6 mg avatrombopag maleate). Other components of Doptelet include lactose monohydrate, colloidal silicon dioxide, crospovidone, and so on.Mechanism of action
Upon administration, Avatrombopag maleate binds to and stimulates TPOR, which may lead to the proliferation and differentiation of megakaryocytes from bone marrow progenitor cells. This increases the production of platelets and may prevent chemotherapy-induced thrombocytopenia (CIT). TPOR is a cytokine receptor and member of the hematopoietin receptor superfamily.Synthesis
The synthesis of Avatrombopag maleate is as follows:A mixture containing 80.1 g of 1-(3-chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexyl piperazin-1-yl) thiazol-2-yl] carbamoyl} pyridin-2-yl) piperidine-4-carboxylic acid, 580 mL of DMSO, 580 mL of acetone, 17.2 g of maleic acid, and 290 mL of water was stirred at 69 °C. The insoluble matter was filtered out, washed with a mixture of 32 mL of DMSO, 32 mL of acetone, and 16 mL of water, and then the filtrate was cooled and the precipitate was collected by filtering. Washing was successively performed using 150 mL of water, 80 mL of acetone, 650 mL of water, and 80 mL of acetone, followed by drying, to obtain 70.66 g of Avatrombopag maleate.
Preparation Products And Raw materials
Avatrombopag maleate Supplier
Global(131)Suppliers
Supplier | Tel | Country | ProdList | Advantage | ||
---|---|---|---|---|---|---|
+86-0086-531-88259693 +86-18660188356 |
tracy.li@zisonpharm.com | China | 57 | 58 | ||
+86-15552509998 +86-15621883869 |
liutf@jewim.com.cn | China | 251 | 58 | ||
+86-18600796368 +86-18600796368 |
sales@sjar-tech.com | China | 456 | 58 | ||
+86-0533-2185556 +8617865335152 |
Mandy@hangyubiotech.com | China | 10986 | 58 | ||
0531-68659554 +8613031714605 |
info@millionpharm.com | China | 252 | 58 | ||
+86-0371-55170693 +86-19937530512 |
info@tianfuchem.com | China | 21634 | 55 | ||
+undefined-21-51877795 | ivan@atkchemical.com | China | 32957 | 60 | ||
+8618957127338 | stella@zetchem.com | China | 2136 | 58 | ||
+1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 | ||
+8613367258412 | ada@ipurechemical.com | China | 10319 | 58 |
Related articles
Avatrombopag Maleate: Preclinical Pharmacology, Pharmacokinetics and Metabolism
Avatrombopag maleate shows potent TPO receptor activation, selective human platelet generation, and promising pharmacokinetics, supporting its development for platelet disorders.
Mar 28,2024
Avatrombopag maleate: Preparation, Appication, Bioactivity
Avatrombopag maleate is indicated for the treatment of thrombocytopenia in adult CLD patients scheduled to undergo medical or dental surgery.
Dec 28,2022
677007-74-8, Avatrombopag maleateRelated Search
PROMPT×
PROMPT
The What'sApp is temporarily not supported in mainland China
The What'sApp is temporarily not supported in mainland China
Cancel
Determine